📢 New KFW Lab paper out now in Science Advances! 📢 We show that AML cells resist chemotherapy by reversing the ATP synthase reaction—supporting oxidative metabolism and maintaining mitochondrial membrane potential. 🔬🧬 👉 science.org/doi/10.1126/sc…

We hope you can join us this summer for the FASEB heme malignancies meeting!!!! We have a fabulous speaker lineup and lots of career development an networking opportunities!

Excited to announce our annual New York City Edward P. Evans MDS Centers Symposium across Memorial Sloan Kettering Cancer Center & Columbia University on Monday, July 14, 2025. This year to be held at Memorial Sloan Kettering Cancer Center. See this flyer below and register here: forms.fillout.com/t/1wX3dGmym4us

Calling all trainees to apply for travel awards for FASEB Heme Malignancies meeting!! Deadline is May 15. This is a fantastic small meeting to attend for early career scientists.

Made a cocktail for my wife and she put it in the freezer, inadvertently creating a new superorganism please hel—*glurk*

Reminder to get your abstracts in for the FASEB Hematologic Malignancies Meeting by June 1st!!! The scientific program is awesome this year and we will have lots of career dev and networking activities!!!

Delighted to share our study out in Cell Stem Cell today from the dream team Elli Papaemmanuil, PhD Iannis Aifantis AK Eisfeld Dan Landau! We profiled IDH-mutated AML patients to define how IDH and co-mutations shape the disease at baseline and responses to IDH-inhibitors. 🧵👇

ASH is committing more than $12 million to address research funding challenges and support the next generation of hematologists. Learn more: ow.ly/sK3050W735W #Fight4Hematology

The hearts started to beat in the pig–human hybrids, which survived for 21 days go.nature.com/4kEoRq7

Excited to share our latest study published in Leukemia (Leukemia Journal): Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome nature.com/articles/s4137…

Congratulations to Drs. Oh and Young on their well deserved faculty promotions! 🥳@washudeptmed hematology.wustl.edu/congratulation…

🚨New Article ONLINE @natureCancer ! 'Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features' ✒️ By John Dick, Charles Mullighan and colleagues 🔗nature.com/articles/s4301…

Looking forward to welcoming everyone to the FASEB Hematologic Malignancies Meeting Sunday!!!!! 🚗If you want to find a carpool from the airport to Southbridge check out the rideshare spreadsheet: faseborg-my.sharepoint.com/:x:/g/personal…

NCI Interim Funding Policy: “With these considerations, we expect to fund through the 4th percentile for those established investigator applications.” “It is expected that funds will be available to reach the 10th percentile for those Early Stage Investigator applications.” 😢

Looking forward to welcoming everyone to the FASEB Heme Malignancies meeting on Sunday! As you are packing, we wanted to let you know that there is a gym, basketball court, and pool on site! Also, options for hiking at the brewery social event! 🏊‍♀️🏀🏋️‍♀️ Safe travels! #HEMSRC

Newly constructed chicken bell for FASEB Heme Malignancy conference #HEMSRC

#hemsrc Thank you to all of our panelists for the career development session at the FASEB hematologic malignancies meeting! Such great advice! Powered by gummy bears….

Such a fun and engaging session last night on Emerging Technologies and Therapies sponsored by AACR! Huge thanks to AACR for their partnership!! #HEMSRC FASEB

The best FASEB meeting with the best people!!! Thank you all for engaging presentations, great questions, and a collaborative and supportive environment!! #HEMSRC @faseborg.bsky.social

Tired of paying $300 for centrifuge adapters? Just 3D print one! printables.com/model/1389317-…